Efforts should continue to further elucidate the currently unexplored roles of mucins MUC4, MUC17, and MUC5AC in the progression of CRC via different pathways, along with their association with various genetic and epigenetic mutations in CRC. This evidence concerns the gene MUC5AC and colorectal carcinoma.